BioAI is an artificial intelligence-based biomedical technology platform with the potential to bring transformative advances to pharmaceutical and medical research. Unlike conventional BioAI platforms, Cadahill's model adopts a multi-target approach to disease research, addressing the complex interactions among medicinal ingredients, bioactive compounds, and disease pathways associated with traditional herbal formulations.
Through an integrated architecture comprising seven interconnected technological layers, the BioAI system enables the systematic tracing of biological mechanisms from clinical observations to the molecular level. This approach offers a pathway for translating traditional medical knowledge, historically grounded in empirical experience and established herbal remedies, into a scientifically substantiated framework based on modern biomedical mechanisms.
In terms of practical applications, BioAI has the potential to accelerate drug candidate screening and support the development of cost-effective treatment strategies for chronic diseases, cancer, cardiovascular conditions, and personalized medicine. The platform also aims to optimize the value chain of natural medicinal resources, providing a foundation for the development of new pharmaceutical products and dietary supplements.
From a broader strategic perspective, developing domestic capabilities in BioAI technology could help Vietnam enhance the value of its biological resources, strengthen national healthcare self-reliance, and deepen its participation in global pharmaceutical value chains.
Senior Colonel Nguyen Thanh Van, Director of the Ministry of Public Security's Traditional Medicine Hospital, highly appreciated the scientific foundation, practical relevance, and potential applications of the BioAI platform.
To translate the proposed collaboration into tangible outcomes, the Hospital Director encouraged relevant departments and professional units to actively explore, exchange ideas, and identify opportunities for cooperation and the practical application of BioAI technology in the hospital's clinical and research activities./.
